NCT07274176

Brief Summary

The primary objective of this study is to utilize the Airofit device to systematically measure and characterize the changes in intraocular pressure across its six different levels of forced expiration. This investigation will provide crucial quantitative data on the IOP-respiratory effort relationship, enhancing our understanding of IOP dynamics during controlled respiratory stress and establishing a new, standardized paradigm for such research.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 27, 2025

Completed
13 days until next milestone

First Posted

Study publicly available on registry

December 10, 2025

Completed
5 days until next milestone

Study Start

First participant enrolled

December 15, 2025

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 10, 2026

Completed
15 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 25, 2026

Completed
Last Updated

December 22, 2025

Status Verified

December 1, 2025

Enrollment Period

2 months

First QC Date

November 27, 2025

Last Update Submit

December 15, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Intraocular Pressure Measurement

    The intraocular pressure will be measured in both eyes using a calibrated Tonoref III non-contact tonometry (Nidek Co., Ltd., Gamagori, Aichi, Japan) and applanation tonometry (A900 tonometer, Costruzione Strumenti Oftalmici, Firenze, Italy) by a single examiner

    T0: Baseline / T1: after 1 minute of forced expiration at Level 1 /T2: after 1 minute of forced expiration at Level 2/T3: Immediately after 1 minute of forced expiration at Level 3

Study Arms (1)

Forced expiration program

EXPERIMENTAL

The participants will be equipped with the Airofit respiratory muscle trainer and will be provided with standardised instructions on performing forced expiration manoeuvres. Participants will be fitted with the Airofit respiratory muscle trainer and given standardized instructions on performing forced expiration maneuvers. * The protocol consisted of sequentially performing forced expiration at each of the device's six predefined resistance levels (Level 1 being the lowest, Level 6 the highest). * The sequence for each level will be identical and as follows: * Exercise Phase: The participant will perform forced expiration maneuvers with the Airofit device for a duration of 5 minute at the specified resistance level. * Immediate Post-Exercise Measurement: Within 5 seconds of completing the exercise minute, IOP will be measured. This measurement will be labeled accordingly: T1 (after Level 1), T2 (after Level 2), up to T6 (after Level 6).

Other: Intraocular Pressure after forced expiration

Interventions

The experiment will entail the acquisition of a total of seven intraocular pressure (IOP) measurements from each subject. * T0: Baseline (pre-intervention, resting). * T1: Immediately after 1 minute of forced expiration at Level 1. * T2: Immediately after 1 minute of forced expiration at Level 2. * T3: Immediately after 1 minute of forced expiration at Level 3. * T4: Immediately after 1 minute of forced expiration at Level 4. * T5: Immediately after 1 minute of forced expiration at Level 5. * T6: Immediately after 1 minute of forced expiration at Level 6.

Forced expiration program

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 18 years or older.
  • Willing and able to provide informed consent.
  • Have a best-corrected visual acuity of 6/12 or better.
  • Able to understand and follow instructions for using the Airofit device.
  • Have an optic nerve cup/disc ratio not exceeding 0.5, and have a c/d difference between both eyes not exceeding 0.2.
  • Did not have taken any anticholinergic medication, systemic beta-blockers, or corticosteroids within the last 3 months that could affect intraocular pressure levels.

You may not qualify if:

  • a history of intraocular surgery,
  • a history of uveitis,
  • a spherical refractive error exceeding 3D,
  • a history of regular topical treatment other than artificial tears

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Usak

Uşak, 64200, Turkey (Türkiye)

RECRUITING

Study Officials

  • Ali Y Karahan, Prof.

    University of Usak

    STUDY CHAIR

Central Study Contacts

Ata Baytaroglu, Asst. Prof.

CONTACT

Serife N Ciftci, Asst. Prof.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SCREENING
Intervention Model
SINGLE GROUP
Model Details: A prospective, cross-sectional, single-visit study designed to measure the acute effect of a standardized respiratory exercise session on intraocular pressure (IOP).
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

November 27, 2025

First Posted

December 10, 2025

Study Start

December 15, 2025

Primary Completion

February 10, 2026

Study Completion

February 25, 2026

Last Updated

December 22, 2025

Record last verified: 2025-12

Locations